Anupam Rasayan India Ltd — Q3 FY26
Anupam Rasayan delivered a strong Q3 FY26 with consolidated revenue of ₹512 crore (+31% YoY) and PAT of ₹61 crore (+12% YoY).
bullish
high
✓ Verified against BSE filing
Claim Ledger
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
90%Questions answered0Evaded / deflected5Questions audited
Answered
Medium priority
EPS impact from J-Hawk acquisition this quarter
Asked by Tanya Chadri, Invest Tech
Management clearly stated no impact yet because the deal hasn't closed.
Read the exchange
Question
I think you mentioned that Jay-Hawk's acquisition will be EPS accretive. So what is the EPS impact this quarter because of the acquisition?
Management (unidentified)
Right now we have not yet consolidated the numbers as the transaction is yet to be completed and hence no contribution of the J-Hawk's revenue or profit has been added to this quarter's results.
Answered
High priority
Strategic plans with the acquired asset
Asked by Harsha, MK Global
Management provided a detailed strategic rationale for the acquisition.
Read the exchange
Question
What are your plans strategically with this asset we are acquiring?
Management (unidentified)
We get a critical manufacturing asset base in US, a large part of revenue from US and performance material business into semiconductors, aerospace, pharma, EV, etc. Also strong cube technologies and validation with high-end customers.
Answered
High priority
Why Anupam was preferred for LiPF6 over global players
Asked by Disha Shamir Maheshwari, N Shiv
Management gave specific factors: supply chain, chemistry capabilities, and long-term partnership.
Read the exchange
Question
Could management please share any additional factors that made Anupam the preferred choice over the two to three other established global players already manufacturing LiPF6?
Management (unidentified)
Offering a full supply chain coupled with technical capabilities of multiple chemistries at scale, and long-term relationship with the customer.
Partial answer
High priority
Why European partners selected Anupam for LiPF6 despite China pricing
Asked by Disha Shamir Maheshwari, N Shiv
Management avoided direct comparison with China pricing, focused on supply chain and capabilities.
did not address China pricing dominance directly
Read the exchange
Question
Could you please elaborate on why these European partners selected Anupam beyond process optimization and tanpack integration especially given China's pricing dominance?
Management (unidentified)
Every customer needs a strong credible supply chain solution, not just import and process. Also chemistry capability to optimize cost as scale up. We also have a US partner, not just European.
Answered
High priority
Working capital days improvement and targets for FY27 and FY28
Asked by Siddhin Natan, JM Financial
Management provided current and target working capital days clearly.
Read the exchange
Question
Could you please give some clarity on how much improvement has been in your working capital days and what your targets are for FY27 and FY28?
Management (unidentified)
As of now we are around about 250 odd days and we expect that in the near term we should be going towards 220 and as you said 27 I think 27 we should be below 200 around 180 days or below.